Economic evaluation plan of a RCT of hydroxyapatite-coated uncemented hemiarthroplasty versus cemented hemiarthroplasty for the treatment of displaced intracapsular hip fractures: the WHiTE5 trial
<p><strong>Aim</strong></p> <p>This paper describes the methods applied to assess the cost-effectiveness of cemented versus uncemented hemiarthroplasty among hip fracture patients in the World Hip Trauma Evaluation Five (WHiTE5) trial.</p> <p><strong>...
| Autori principali: | , , , , , , , |
|---|---|
| Natura: | Journal article |
| Lingua: | English |
| Pubblicazione: |
British Editorial Society of Bone and Joint Surgery
2020
|
| _version_ | 1826303989193375744 |
|---|---|
| author | Png, ME Fernandez, MA Achten, J Parsons, N McGibbon, A Gould, J Griffin, X Costa, ML |
| author_facet | Png, ME Fernandez, MA Achten, J Parsons, N McGibbon, A Gould, J Griffin, X Costa, ML |
| author_sort | Png, ME |
| collection | OXFORD |
| description | <p><strong>Aim</strong></p>
<p>This paper describes the methods applied to assess the cost-effectiveness of cemented versus uncemented hemiarthroplasty among hip fracture patients in the World Hip Trauma Evaluation Five (WHiTE5) trial.</p>
<p><strong>Methods</strong></p>
<p>A within-trial cost-utility analysis (CUA) will be conducted at four months postinjury from a health system (National Health Service and personal social services) perspective. Resource use pertaining to healthcare utilization (i.e. inpatient care, physiotherapy, social care, and home adaptations), and utility measures (quality-adjusted life years) will be collected at one and four months (primary outcome endpoint) postinjury; only treatment of complications will be captured at 12 months. Sensitivity analysis will be conducted to assess the robustness of the results.</p>
<p><strong>Conclusion</strong></p>
<p>The planned analysis strategy described here records our intent to conduct a within-trial CUA alongside the WHiTE5 trial.</p> |
| first_indexed | 2024-03-07T06:11:03Z |
| format | Journal article |
| id | oxford-uuid:ef7f8ee4-32b6-4caa-b00d-7e30f210e70a |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T06:11:03Z |
| publishDate | 2020 |
| publisher | British Editorial Society of Bone and Joint Surgery |
| record_format | dspace |
| spelling | oxford-uuid:ef7f8ee4-32b6-4caa-b00d-7e30f210e70a2022-03-27T11:40:46ZEconomic evaluation plan of a RCT of hydroxyapatite-coated uncemented hemiarthroplasty versus cemented hemiarthroplasty for the treatment of displaced intracapsular hip fractures: the WHiTE5 trialJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ef7f8ee4-32b6-4caa-b00d-7e30f210e70aEnglishSymplectic ElementsBritish Editorial Society of Bone and Joint Surgery2020Png, MEFernandez, MAAchten, JParsons, NMcGibbon, AGould, JGriffin, XCosta, ML<p><strong>Aim</strong></p> <p>This paper describes the methods applied to assess the cost-effectiveness of cemented versus uncemented hemiarthroplasty among hip fracture patients in the World Hip Trauma Evaluation Five (WHiTE5) trial.</p> <p><strong>Methods</strong></p> <p>A within-trial cost-utility analysis (CUA) will be conducted at four months postinjury from a health system (National Health Service and personal social services) perspective. Resource use pertaining to healthcare utilization (i.e. inpatient care, physiotherapy, social care, and home adaptations), and utility measures (quality-adjusted life years) will be collected at one and four months (primary outcome endpoint) postinjury; only treatment of complications will be captured at 12 months. Sensitivity analysis will be conducted to assess the robustness of the results.</p> <p><strong>Conclusion</strong></p> <p>The planned analysis strategy described here records our intent to conduct a within-trial CUA alongside the WHiTE5 trial.</p> |
| spellingShingle | Png, ME Fernandez, MA Achten, J Parsons, N McGibbon, A Gould, J Griffin, X Costa, ML Economic evaluation plan of a RCT of hydroxyapatite-coated uncemented hemiarthroplasty versus cemented hemiarthroplasty for the treatment of displaced intracapsular hip fractures: the WHiTE5 trial |
| title | Economic evaluation plan of a RCT of hydroxyapatite-coated uncemented hemiarthroplasty versus cemented hemiarthroplasty for the treatment of displaced intracapsular hip fractures: the WHiTE5 trial |
| title_full | Economic evaluation plan of a RCT of hydroxyapatite-coated uncemented hemiarthroplasty versus cemented hemiarthroplasty for the treatment of displaced intracapsular hip fractures: the WHiTE5 trial |
| title_fullStr | Economic evaluation plan of a RCT of hydroxyapatite-coated uncemented hemiarthroplasty versus cemented hemiarthroplasty for the treatment of displaced intracapsular hip fractures: the WHiTE5 trial |
| title_full_unstemmed | Economic evaluation plan of a RCT of hydroxyapatite-coated uncemented hemiarthroplasty versus cemented hemiarthroplasty for the treatment of displaced intracapsular hip fractures: the WHiTE5 trial |
| title_short | Economic evaluation plan of a RCT of hydroxyapatite-coated uncemented hemiarthroplasty versus cemented hemiarthroplasty for the treatment of displaced intracapsular hip fractures: the WHiTE5 trial |
| title_sort | economic evaluation plan of a rct of hydroxyapatite coated uncemented hemiarthroplasty versus cemented hemiarthroplasty for the treatment of displaced intracapsular hip fractures the white5 trial |
| work_keys_str_mv | AT pngme economicevaluationplanofarctofhydroxyapatitecoateduncementedhemiarthroplastyversuscementedhemiarthroplastyforthetreatmentofdisplacedintracapsularhipfracturesthewhite5trial AT fernandezma economicevaluationplanofarctofhydroxyapatitecoateduncementedhemiarthroplastyversuscementedhemiarthroplastyforthetreatmentofdisplacedintracapsularhipfracturesthewhite5trial AT achtenj economicevaluationplanofarctofhydroxyapatitecoateduncementedhemiarthroplastyversuscementedhemiarthroplastyforthetreatmentofdisplacedintracapsularhipfracturesthewhite5trial AT parsonsn economicevaluationplanofarctofhydroxyapatitecoateduncementedhemiarthroplastyversuscementedhemiarthroplastyforthetreatmentofdisplacedintracapsularhipfracturesthewhite5trial AT mcgibbona economicevaluationplanofarctofhydroxyapatitecoateduncementedhemiarthroplastyversuscementedhemiarthroplastyforthetreatmentofdisplacedintracapsularhipfracturesthewhite5trial AT gouldj economicevaluationplanofarctofhydroxyapatitecoateduncementedhemiarthroplastyversuscementedhemiarthroplastyforthetreatmentofdisplacedintracapsularhipfracturesthewhite5trial AT griffinx economicevaluationplanofarctofhydroxyapatitecoateduncementedhemiarthroplastyversuscementedhemiarthroplastyforthetreatmentofdisplacedintracapsularhipfracturesthewhite5trial AT costaml economicevaluationplanofarctofhydroxyapatitecoateduncementedhemiarthroplastyversuscementedhemiarthroplastyforthetreatmentofdisplacedintracapsularhipfracturesthewhite5trial |